Compare CTM & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTM | CSBR |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | N/A | 214 |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.1M | 68.8M |
| IPO Year | 2022 | 2015 |
| Metric | CTM | CSBR |
|---|---|---|
| Price | $0.63 | $4.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 423.6K | 12.5K |
| Earning Date | 11-06-2026 | 09-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $52,866,001.00 | $2,900,000.00 |
| Revenue This Year | $6.00 | $9.83 |
| Revenue Next Year | $7.11 | $8.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.10 | N/A |
| 52 Week Low | $0.48 | $4.59 |
| 52 Week High | $1.36 | $8.31 |
| Indicator | CTM | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 46.98 |
| Support Level | $0.59 | $4.71 |
| Resistance Level | $0.65 | $6.31 |
| Average True Range (ATR) | 0.02 | 0.26 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 44.02 | 36.19 |
Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.